Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1927
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase II Study of Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Adenocarcinomas

British Journal of Cancer
Cancer ResearchOncology
2013English

A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

Oncology
MedicineCancer ResearchOncology
2012English

A Phase I Trial Investigating Pulsatile Erlotinib in Combination With Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancers

Investigational New Drugs
OncologyPharmacology
2016English

Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers

Clinical Colorectal Cancer
OncologyGastroenterology
2014English

Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers

Oncologist
Cancer ResearchMedicineOncology
2015English

Phase I Study of Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin in Patients With Biliary Tract Cancer Undergoing Curative Resection Without Major Hepatectomy (KHBO1004).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy